-
Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in…
25 Sep 2025 10:00 GMT
… its majority owned subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”) (OTC … first-line treatment and the only FDA-approved, ready … of the anti-gout medicine colchicine indicated for the … candidates, planned clinical trials and preclinical activities and …
-
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Se…
23 Sep 2025 15:12 GMT
… clinical late-stage specialty pharmaceutical company focused on the … potential first-line treatment and the only FDA-approved, ready … of the anti-gout medicine colchicine indicated for the … candidates, planned clinical trials and preclinical activities and …
-
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
23 Sep 2025 14:00 GMT
… its majority owned subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”) (OTC … first-line treatment and the only FDA-approved, ready … of the anti-gout medicine colchicine indicated for the … candidates, planned clinical trials and preclinical activities and …
-
Myocarditis Guidelines Clarify Diagnosis and Treatment of a ‘Silent Killer’
23 Sep 2025 12:59 GMT
… treatment-refractory cases,” said Gianfranco Sinagra, MD, head of cardiothoracovascular medicine … use of colchicine in combination with nonsteroidal anti-inflammatory drugs. In … Cardiol Therapeutics, and Foresee Pharmaceuticals and equity ownership in Stromal …
-
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 202…
23 Sep 2025 10:00 GMT
… clinical late-stage specialty pharmaceutical company focused on the … potential first-line treatment and the only FDA-approved, ready … of the anti-gout medicine colchicine indicated for the … candidates, planned clinical trials and preclinical activities and …
-
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination
22 Sep 2025 19:49 GMT
… majority-owned subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and … potential first-line treatment and the only FDA-approved, ready … of the anti-gout medicine colchicine indicated for the … candidates, planned clinical trials and preclinical activities and …
-
Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
25 Sep 2025 19:45 GMT
… potential first-line treatment and the only FDA-approved, ready … of the anti-gout medicine colchicine indicated for the prophylaxis … for RWA in the biotech and pharmaceutical industry, Scilex’s … candidates, planned clinical trials and preclinical activities and …
-
Scilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury Management
24 Sep 2025 14:11 GMT
… potential first-line treatment and the only FDA-approved, ready … of the anti-gout medicine colchicine indicated for the … pain/sciatica. Semnur Pharmaceuticals, Inc. is headquartered … candidates, planned clinical trials and preclinical activities and …
-
You might be interested in…Cardiovascular Disease Update (Part 1)
23 Sep 2025 08:13 GMT
… . Data from recent trials have suggested that colchicine reduces the risk of … placebo.
The results of the colchicine trial are reported in this paper … years. The conclusion was that treatment with colchicine, when started soon after …
-
Sex Differences in Patients with Heart Failure with Reduced Ejection Fraction Combined with Anemia and Hyperuricemia: A Retrospective Case Study
22 Sep 2025 13:16 GMT
… inhibitors, uric acid-lowering drugs, and colchicine; (2) those with … on the Diagnosis and Treatment of Hyperuricemia and Related … collected by reviewing electronic medical records or through telephone … the ISCHEMIA randomized clinical trial. JAMA Cardiol. 2020 …
About
© 1995-2025